Gilead Sciences: Latinas Contra Cancer Empowers Patients To Advocate for Change Pharmaceutical Investing
Seelos Therapeutics Announces Data Demonstrating Downregulation of Alpha Synuclein in an In Vivo Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 in Parkinson's Disease Psychedelics Investing
Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023 Pharmaceutical Investing
Medtronic announces first patient enrolled in U.S. clinical trial for Hugo robotic-assisted surgery system Medical Device Investing
AstraZeneca and Merck Provide Update on US Regulatory Review of LYNPARZA® in Combination With Abiraterone and Prednisone or Prednisolone as Treatment of Metastatic Castration-Resistant Prostate Cancer Life Science Investing
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022 Pharmaceutical Investing
Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions Pharmaceutical Investing
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA , Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial Life Science Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
